0001209191-23-057258.txt : 20231204
0001209191-23-057258.hdr.sgml : 20231204
20231204170026
ACCESSION NUMBER: 0001209191-23-057258
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231201
FILED AS OF DATE: 20231204
DATE AS OF CHANGE: 20231204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Puttagunta Sailaja
CENTRAL INDEX KEY: 0001792314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38503
FILM NUMBER: 231464084
MAIL ADDRESS:
STREET 1: C/O BIOMX LTD.
STREET 2: 7 PINHAS SAPIR ST., FLOOR 2
CITY: NESS ZIONA
STATE: L3
ZIP: 7414002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Iterum Therapeutics plc
CENTRAL INDEX KEY: 0001659323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FITZWILLIAM COURT, 1ST FLOOR
STREET 2: LEESON CLOSE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 YW24
BUSINESS PHONE: (872) 225-6077
MAIL ADDRESS:
STREET 1: FITZWILLIAM COURT, 1ST FLOOR
STREET 2: LEESON CLOSE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 YW24
FORMER COMPANY:
FORMER CONFORMED NAME: Iterum Therapeutics Ltd
DATE OF NAME CHANGE: 20151124
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-01
0
0001659323
Iterum Therapeutics plc
ITRM
0001792314
Puttagunta Sailaja
C/O ITERUM THERAPEUTICS PLC
FITZWILLIAM COURT, FL. 1, LEESON CLOSE
DUBLIN 2
L2
IRELAND
0
1
0
0
Chief Medical Officer
0
Ordinary Shares
2023-12-01
4
A
0
8333
0.00
A
13302
D
Ordinary Shares
2023-12-01
4
F
0
2933
2.12
D
10369
D
Restricted Share Units
2023-12-01
4
M
0
8333
0.00
D
Ordinary Shares
8333
16666
D
On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.
Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
Represents the ordinary shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted RSUs.
The number of RSUs reported on this Form 4 have been adjusted to reflect the Reverse Share Split.
On December 1, 2021, the reporting person was granted an award of 33,333 RSUs, 25% of which vested on December 1, 2022, with a further 25% having vested on December 1, 2023.
/s/ Sailaja Puttagunta
2023-12-04